James Haft's most recent trade in Applied Dna Sciences Inc was a trade of 77,038 Non-Qualified Stock Option (right to buy) done . Disclosure was reported to the exchange on March 27, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Applied Dna Sciences Inc | James Haft | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2026 | 77,038 | 77,038 | - | - | Non-Qualified Stock Option (right to buy) | |
| Applied Dna Sciences Inc | James Haft | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 80,730 | 80,730 | - | - | Incentive Stock Option (right to buy) | |
| Applied Dna Sciences Inc | James Haft | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 12,270 | 12,270 | - | - | Non-Qualified Stock Option (right to buy) |